ClinVar Miner

Submissions for variant NM_000558.3(HBA1):c.389T>C (p.Leu130Pro) (rs35993655)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000756223 SCV000883968 likely pathogenic not provided 2018-06-29 criteria provided, single submitter clinical testing The Hb Tunis-Bizerte variant (HBA1: c.389T>C; Leu129Pro) (rs35993655), has been described in the heterozygous state in individuals with no clinical presentation, but in the homozygous state in an individual with marked anemia and microcytosis (Darbellay 1995, HbVar database). Based on mass spectrometric analysis of the globins from both a heterozygote and homozygote, these authors concluded that the HBA1 chain harboring Leu129Pro represented <1% of the alpha globin chains and, thus, the variant is associated with a thalassemic phenotype. This variant is listed in ClinVar (Variation ID: 15865), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. Additionally, the corresponding amino acid change in HBA2 (Leu129Pro, Hb Utrecht) is predicted to be very unstable, with heterozygous carriers reported with a mild alpha-thalassemic phenotype (Harteveld 1996, HbVar database). The lysine at codon 129 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available evidence, the Hb Tunis-Bizerte variant is predicted to be likely pathogenic for alpha-thalassemia, although to the best of our knowledge its effect in combination with deletional alpha thalassemia variants is not known. References: Link to HbVar database for Hb Tunis-Bizerte: Link to HbVar database for Hb Utrecht: Darbellay R et al. Haemoglobin Tunis-Bizerte: a new alpha 1 globin 129 Leu>Pro unstable variant with thalassaemic phenotype. Br J Haematol. 1995 May;90(1):71-6. Harteveld CL et al. Hb Utrecht (alpha 2 129(H12)Leu-->Pro), a new unstable alpha 2-chain variant associated with a mild alpha-thalassaemic phenotype. Br J Haematol. 1996 Sep;94(3):483-5.
OMIM RCV000017211 SCV000037483 other HEMOGLOBIN TUNIS-BIZERTE 2016-07-20 no assertion criteria provided literature only
Natera, Inc. RCV001276182 SCV001462082 likely pathogenic alpha Thalassemia 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.